AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Pneumococcal vaccine not useful in HIV patients responding to HAART.

Vaccine Weekly

| May 05, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 MAY 5 - (NewsRx.com & NewsRx.net) -- The 23-valent pneumococcal vaccine does not offer additional protection against pneumonia in HIV-infected patients who have an immunological response to highly active antiretroviral therapy (HAART).

"The objective of this study was to assess the factors implicated in an increased or decreased risk of pneumonia, with particular attention to the response to HAART and the effect of the polysaccharide 23-valent pneumococcal vaccination in 300 human immunodeficiency virus (HIV)-infected adults followed-up for a median of 35.6 months. Pneumococcal pneumonia occurred in 12 patients and all bacterial pneumonia (pneumonia caused by Streptococcus pneumoniae or other bacteria, as well as those with negative cultures but presumably bacterial in origin) in 40 patients," scientists in Spain report.

"In the univariate analysis, immunodepressed patients (defined as those with less than 200 CD4+ T cell/microliter), those without immunological response to HAART (defined as an increase of 25% of CD4+ T lymphocyte count), patients with previous admissions to hospital and those with cotrimoxazole or Mycobacterium avium intracellulare prophylaxis showed a higher incidence of both pneumococcal and all bacterial pneumonia," stated C. Lopez-Palomo and colleagues at the Hospital Universitario Puerta del Mar. "Multivariate analysis demonstrated that the presence of pneumococcal pneumonia was associated with a CD4+ lymphocyte count at the time of HIV diagnosis

"The multivariate model that was ...

Related articles from newspapers, magazines, journals, and more
Pneumococcal vaccine not useful in HIV patients responding to HAART.
Newspaper article from: Immunotherapy Weekly May 5, 2004 700+ words
...The 23-valent pneumococcal vaccine does not offer additional...antiretroviral therapy (HAART). "The objective...immunological response to HAART, a near significant...effect of 23-valent pneumococcal vaccine in HIV-patients with...immunological response to HAART." ...
Pneumococcal vaccine schedule questions persist.(Infectious Diseases)
Magazine article from: Family Practice News Tucker, Miriam E. August 1, 2008 700+ words
...administering two doses of PCV7 followed by PPV23 in HIV-infected children aged 5-17 years on highly active antiretivinal therapy (HAART) who were not previously immunized with PCV7. The ACIP also agreed with the working group's prior decision not to recommend...
Rare systemic dermatologic reaction after pneumococcal vaccine administration....
Magazine article from: Southern Medical Journal Holdiness, Mack R. January 1, 2003 700+ words
...patient after administration of pneumococcal vaccine. A 65-year-old man developed...reactions with vaccines, such as the pneumococcal vaccine, which in general have a good safety...40,000 deaths annually. (1) Pneumococcal vaccine has been available for commercial...
FDA Told Pneumococcal Vaccine Likely to Cause Epidemic of Diabetes.
Press release article from: PR Newswire November 8, 1999 700+ words
...testimony that the conjugated 7-valent pneumococcal vaccine was likely to cause a large epidemic...recommend approval of a new conjugated pneumococcal vaccine intended for preventing meningitis...the hemophilus vaccine that the pneumococcal vaccine could cause a major epidemic of...
Conjugate Pneumococcal Vaccine May Shift Otitis Etiology.
Magazine article from: Family Practice News TUCKER, MIRIAM E. November 1, 1999 700+ words
...otitis media once the conjugate pneumococcal vaccine becomes firmly entrenched in the...how. The heptavalent conjugate pneumococcal vaccine, manufactured by Wyeth-Lederle...strains covered in the conjugate pneumococcal vaccine: 16% were serotype 19F; 10...
Pneumococcal vaccine ineffective at CAP prevention.(community-acquired...
Newspaper article from: Sports Medicine Reports Elliott, William T. June 1, 2003 700+ words
Pneumococcal vaccine protects older adults from developing...bacteremia. Prior receipt of the pneumococcal vaccine was associated with a reduction...no reduction of CAP with the pneumococcal vaccine. They state, however, that...
Polysaccharide pneumococcal vaccine not protective in adults.
Newspaper article from: TB & Outbreaks Week March 25, 2003 700+ words
...indicates that the polysaccharide pneumococcal vaccine does not significantly protect against...of the 23-valent polysaccharide pneumococcal vaccine in adult populations in the more...Diseases (Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries...
Responses to pneumococcal vaccine in IgA deficient patients studied.
Newspaper article from: Biotech Week June 30, 2004 700+ words
...clinical correlates and responses to pneumococcal vaccine in patients with an IgA deficiency...history of recurring infections and pneumococcal vaccine responses; HLA status was not related...clinical correlates and responses to pneumococcal vaccine. Clin Immunol, 2004;111(1...
For more facts and information, see all results

Source: HighBeam Research, Pneumococcal vaccine not useful in HIV patients responding to HAART.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA